Related Experiment Video

Updated: Aug 11, 2026

Generation of Large Numbers of Myeloid Progenitors and Dendritic Cell Precursors from Murine Bone Marrow Using a Novel Cell Sorting Strategy
09:05

Generation of Large Numbers of Myeloid Progenitors and Dendritic Cell Precursors from Murine Bone Marrow Using a Novel Cell Sorting Strategy

Published on: August 10, 2018

Generation and characterization of a novel hematopoietic progenitor cell line with DC differentiation potential

C Rathinam1, M Sauer, A Ghosh

  • 1Department of Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany.

Leukemia
|March 3, 2006
PubMed

Insights

Researchers developed a new cell line, CR1, from hematopoietic stem cells (HSCs) to overcome their rarity. These CR1 cells effectively model dendritic cell (DC) development and function for immunotherapy research.

Area of Science:

  • Immunology
  • Cell Biology
  • Stem Cell Research

Background:

  • Hematopoietic stem cell (HSC)-derived dendritic cells (DCs) are crucial for immune responses but are limited by HSC rarity.
  • Studying DC development and function is vital for advancing immunotherapy.

Purpose of the Study:

  • To generate a novel cell line for studying dendritic cells (DCs).
  • To establish a reproducible model for DC research and preclinical immunotherapy.

Main Methods:

  • Generated the CR1 cell line via retroviral Notch(IC) gene transfer into Sca1(+)ckit(+)lin- HSC.
  • Cultured CR1 cells in vitro with recombinant interleukin-3 for proliferation.
  • Induced differentiation into myeloid and plasmacytoid DCs using GM-CSF or Flt3L.

Main Results:

  • CR1 cells proliferated in vitro, maintaining an immature progenitor phenotype and intact karyotype.
  • CR1 cells differentiated into both myeloid and plasmacytoid DCs upon stimulation.
  • CR1 cells demonstrated functional comparability to primary bone-marrow-derived DCs in maturation and immune response induction.

Conclusions:

  • The CR1 cell line offers a valuable and accessible tool for studying dendritic cell development and function.
  • CR1 cells serve as a promising model for preclinical evaluation of DC-based immunotherapies.
  • This novel cell line facilitates research into immune responses and therapeutic strategies.

More Related Videos

Pan-myeloid Differentiation of Human Cord Blood Derived CD34+ Hematopoietic Stem and Progenitor Cells10:25

Pan-myeloid Differentiation of Human Cord Blood Derived CD34+ Hematopoietic Stem and Progenitor Cells

Published on: August 9, 2019

Directed Differentiation of Primitive and Definitive Hematopoietic Progenitors from Human Pluripotent Stem Cells14:37

Directed Differentiation of Primitive and Definitive Hematopoietic Progenitors from Human Pluripotent Stem Cells

Published on: November 1, 2017

Related Concept Videos

Lineage Commitment01:21

Lineage Commitment

Commitment is the  process whereby stem cells:
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
Hematopoiesis01:21

Hematopoiesis

The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
Production of Formed Elements01:34

Production of Formed Elements

Hemangioblasts are multipotent stem cells originating from the mesoderm. They give rise to hematopoietic stem cells (HSCs), which undergo hematopoiesis to produce all the formed elements of blood. This process is regulated by a complex network of hematopoietic growth factors, including transcription factors, growth factors, and cytokines. These factors stimulate the HSCs to divide and differentiate, though some HSCs remain undifferentiated to maintain a self-renewing pool.
Most HSCs commit to...